Clinical trial
Comparative Study of Zonisamide and Carbamazepine as an Initial Monotherapy: Efficacy and Safety Evaluation
NCT01127256 is registered in ClinicalTrials.gov with Eisai Korea Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparative Study of Zonisamide and Carbamazepine as an Initial Monotherapy: Efficacy and Safety Evaluation
- Lead sponsor
- Eisai Korea Inc.
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- May 31, 2006
- Completion date
- July 31, 2009
- Enrollment
- 200 (actual)
- Sites
- 12
Conditions
As the registry lists them; a condition with its own page is linked.